Dasgupta Flashcards
MOPP
Hodgkin’s disease
ABVD
Hodgkin’s disease
CHOP
Non-Hodgkin’s Lymphoma
CMF
Breast
CAF
Breast
PACE
Small cell lung cancer
VIP
Germ cell
BIP
Cervical
M-BACOD
Lymphomas
BEP
Ovarian
CVD
Pheochromocytoma
PEB
Testicular
G1 phase of cell cycle
Cell contents other than chromosomes are duplicated
S phase of cell cycle
DNA is replicated
G2 phase of cell cycle
Preparing for division (proteins produced, spindle apparatus forms)
M phase of cell cycle
Cell division
G0 phase of cell cycle
Resting cell
Alkylating agents: MOA
Add methyl (other alkyl group) to guanine residue of DNA causing cross-bridging between DNA nucleotides
Alkylating agent causing cross-linking between 2 DNA strands vs cross-linking between 2 residues on 1 DNA strand
Cross-linking between 2 strands = GOOD
Cross-linking of 2 residues on 1 strand results in increased ability to develop mutations that lead to resistance (due to DNA repair causing fragmentation)
Name 3 main alkylating agents
- Mustragen (mechlorethamine)
- Cyclophosphamide
- Chlorambucil
These are the other ones:
- Estramustine phosphate
- Busulfan
- Nitrosureas (streptozocin, procarbazine, dacarbazine)
Unique property of mustragen (mechlorethamine)
NOT excreted
What disease is mustragen commonly used to treat
Hodgkin’s disease (along with other chemotherapy agents)
Unique property of cyclophosphamide
Must be activated by p450
2 Unique toxicities of cyclophosphamide
- Hemorrhagic cystitis
- SIADH (water intoxication)
What 3 diseases is cyclophosphamide used to treat
- Burkitt’s lymphoma
- Acute lymphocytic leukemia
- Other lymphomas/leukemias
Drug that is generally administered to decrease side effect of hemorrhagic cystitis
MESNA (Mercaptoethanesulfonate)
How does MESNA work?
Reacts with acrolein (toxic by product of cyclophosphamide metabolism) in urine and detoxifies it
Estramustine phosphate route of administration and unique therapeutic effects
- Can be given orally
- Anti-mitotic effect in addition to alkylating effect
Unique toxicity with busulfan
Pulmonary fibrosis and hyper-pigmentation of the skin
Unique toxicity with nitrosureas
Pulmonary fibrosis and nephrotoxicity
What alkylating agent is given as a first line therapy for brain tumors? Why?
Nitrosureas due to being lipophilic
What should patients taking procarbazine avoid?
- MAOInhibitors
- Alcohol
*cause rapid increase in BP
Dacarbazine: MOA
Methylates DNA and RNA
Cisplatin: MOA
Intrastrand crossling by binding to guanine
What element is contained in cisplatin
Platinum
What is the hallmark side effect involving platinum drugs
NEPHROTOXICITY
What is generally administered with all chemotherapeutic agents? Why?
- Normal saline for hydration
- Eliminate toxic metabolites and flush out the chemotherapy quickly
Are alkylating agents CCS or CCNS?
CCNS
Are platinum containing agents CCS or CCNS?
CCNS
2 major drugs in the anthracycline category
- Doxorubicin
2. Daunorubicin
Antracycline: MOA
- Intercalation of 2 strands of DNA, inhibiting topoisomerase
- Cause single and double strand DNA breaks
- Histone eviction
Are anthracyclines CCS or CCNS?
CCNS
Unique toxicity with anthracyclines
Cardiotoxicity
What drug can be administered with anthracyclines to reduce there unique toxic side effect
Dexrazoxane
What drug has a similar mechanism of action to doxorubicin but has decreased incidence of cardiotoxicity
Mitoxantrone
*Note if cardiotoxicity is seen with this drug however, it is SEVERE
Main 2 drugs in the topoisomerase II inhibitor category
- Etoposide
- Tenopside
Topoisomerase II active agent: MOA
Forms an inhibitory complex with DNA-topoisomerase II
Main cancers that topoisomerase II inhibitors are used in
- Testicular
- Small-cell lung cancer
Are topoisomerase II inhibitors CCS or CCNS?
CCS = S and G2 phase
Camptothecin Analog: MOA
Inhibitors of topoisomerase I